Champions Oncology (CSBR) Short Interest Ratio & Short Volume

Short interest is the volume of Champions Oncology shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 108,900 shares of CSBR short. 1.79% of Champions Oncology's shares are currently sold short. Learn More on Champions Oncology's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CSBR shares currently have a short interest ratio of 2.0. Learn More on Champions Oncology's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.79% of Champions Oncology's floating shares are currently sold short.

Champions Oncology saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 108,900 shares, a decline of 38.3% from the previous total of 176,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Champions Oncology currently has issued a total of 13,820,000 shares. Some of Champions Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Champions Oncology currently has a public float of 6,100,000 shares.

1.79% of Champions Oncology's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Champions Oncology: MeiraGTx Holdings plc (2.56%), ProKidney Corp. (12.61%), Tourmaline Bio, Inc. (14.94%), Aura Biosciences, Inc. (3.14%), Allogene Therapeutics, Inc. (15.43%), Kodiak Sciences Inc. (3.52%), REGENXBIO Inc. (12.29%), Compass Therapeutics, Inc. (3.83%), Valneva SE (0.03%), Monte Rosa Therapeutics, Inc. (19.06%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

Short selling CSBR is an investing strategy that aims to generate trading profit from Champions Oncology as its price is falling. CSBR shares are trading up $1.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Champions Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CSBR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CSBR, twice per month. The most recent reporting period available is January, 15 2025.